Name: Name:1,2,5-Oxadiazole, 3,4-bis(phenylsulfonyl)-, 2-oxide
Brand: Angene
SKU: AG00H8KI
Rating: 90 (10 reviews)

1,2,5-Oxadiazole, 3,4-bis(phenylsulfonyl)-, 2-oxide

CAS No.:

66074-00-8

Catalog Number:

AG00H8KI

Molecular Formula:

C14H10N2O6S2

Molecular Weight:

366.3690

Pack Size

Purity

Availability

Location

Price(USD)

Quantity

Product Description

Catalog Number:

AG00H8KI

Chemical Name:

1,2,5-Oxadiazole, 3,4-bis(phenylsulfonyl)-, 2-oxide

CAS Number:

66074-00-8

Molecular Formula:

C14H10N2O6S2

Molecular Weight:

366.3690

MDL Number:

MFCD02110435

IUPAC Name:

3,4-bis(benzenesulfonyl)-2-oxido-1,2,5-oxadiazol-2-ium

InChI:

InChI=1S/C14H10N2O6S2/c17-16-14(24(20,21)12-9-5-2-6-10-12)13(15-22-16)23(18,19)11-7-3-1-4-8-11/h1-10H

InChI Key:

PLIHJANRRMFJCC-UHFFFAOYSA-N

SMILES:

[O-][n+]1onc(c1S(=O)(=O)c1ccccc1)S(=O)(=O)c1ccccc1

Properties

Complexity:

627

Compound Is Canonicalized:

Yes

Covalently-Bonded Unit Count:

Defined Atom Stereocenter Count:

Defined Bond Stereocenter Count:

Exact Mass:

365.998g/mol

Formal Charge:

Heavy Atom Count:

Hydrogen Bond Acceptor Count:

Hydrogen Bond Donor Count:

Isotope Atom Count:

Molecular Weight:

366.362g/mol

Monoisotopic Mass:

365.998g/mol

Rotatable Bond Count:

Topological Polar Surface Area:

137A^2

Undefined Atom Stereocenter Count:

Undefined Bond Stereocenter Count:

XLogP3:

2.2

Literature

Title	Journal
Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.	European journal of medicinal chemistry 20101201
Phenylsulfonylfuroxans as modulators of multidrug-resistance-associated protein-1 and P-glycoprotein.	Journal of medicinal chemistry 20100812
Furoxan-, alkylnitrate-derivatives and related compounds as anti-trypanosomatid agents: mechanism of action studies.	Bioorganic & medicinal chemistry 20080901
Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.	Journal of medicinal chemistry 20040325